Silence Therapeutics Plc Revenue per Employee (SLN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Silence Therapeutics Plc  (NASDAQ: SLN)
 

Silence Therapeutics Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Silence Therapeutics Plc's Revenue per employee fell on a trailing twelve month basis to $ 6,989, but the productivity of Silence Therapeutics Plc's employees remained above the company average.
Within the Healthcare sector Employees of 537 other companies have achieved higher revenue per employee. While Silence Therapeutics Plc's total ranking has deteriorated compared to the previous quarter from 2689 to 3544. Silence Therapeutics Plc has 88 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SLN Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - 197.18 % -99.87 % -89.39 % -70.37 %
Sales per Employee (TTM) $ 6,989 9,534 6,352 293,523 308,739
SLN's Total Ranking # 3544 # 2689 # 2452 # 897 # 1269
Seq. Revenue Change - 1141.18 % -78.62 % -29.02 % 57.75 %

SLN Company Profile >> Back to SLN Efficiency Comparisons >> Compare SLN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 193
Healthcare Sector # 538
Overall Market # 3544

Revenue per Employee Statistics
High Average Low
$ 509,591 $ 267,756 $ 6,352
(Mar 31 2025)   (Dec 31 2025)



Financial Statements
Silence Therapeutics Plc's Revenue MRQ $ 0 Millions Visit SLN's Income Statement
Silence Therapeutics Plc's Revenues TTM $ 1 Millions Visit SLN's aggregate revenue growth
What are SLN's Sales? Visit SLN's Sales by Segment




Other Ratios
Silence Therapeutics Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SLN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SLN's Competitors
Revenue per Employee for SLN's Suppliers
Revenue per Employee for SLN's Customers

You may also want to know
SLN's Sales Growth Rates SLN's Pe Price to earnings ratio SLN's Receivables Turnover Ratio SLN's Stock Quote
SLN's Net Income Growth Rates SLN's Ps Price to Sales ratio SLN's Sales per Employee SLN's Asset Turnover Ratio
SLN's Net Margin SLN's Pb Price to Book ratio SLN's Financial Strength Ratios SLN's Dividend Payout Ratio
Date modified: 2026-08-31T19:03:44+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Lightwave Logic Inc   7,360.32 $ 0.250  Million 34 
Prokidney Corp   3,541.13 $ 0.818  Million 231 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.